skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Serum markers for type II diabetes mellitus

Abstract

A method for identifying persons with increased risk of developing type 2 diabetes mellitus utilizing selected biomarkers described hereafter either alone or in combination. The present invention allows for broad based, reliable, screening of large population bases and provides other advantages, including the formulation of effective strategies for characterizing, archiving, and contrasting data from multiple sample types under varying conditions.

Inventors:
; ; ; ; ;
Issue Date:
Research Org.:
Pacific Northwest National Lab. (PNNL), Richland, WA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1127136
Patent Number(s):
8673644
Application Number:
12/120,043
Assignee:
Battelle Memorial Institute (Richland, WA)
Patent Classifications (CPCs):
G - PHYSICS G01 - MEASURING G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
DOE Contract Number:  
AC05-76RLO1830
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Metz, Thomas O, Qian, Wei-Jun, Jacobs, Jon M, Polpitiya, Ashoka D, Camp, II, David G, and Smith, Richard D. Serum markers for type II diabetes mellitus. United States: N. p., 2014. Web.
Metz, Thomas O, Qian, Wei-Jun, Jacobs, Jon M, Polpitiya, Ashoka D, Camp, II, David G, & Smith, Richard D. Serum markers for type II diabetes mellitus. United States.
Metz, Thomas O, Qian, Wei-Jun, Jacobs, Jon M, Polpitiya, Ashoka D, Camp, II, David G, and Smith, Richard D. Tue . "Serum markers for type II diabetes mellitus". United States. https://www.osti.gov/servlets/purl/1127136.
@article{osti_1127136,
title = {Serum markers for type II diabetes mellitus},
author = {Metz, Thomas O and Qian, Wei-Jun and Jacobs, Jon M and Polpitiya, Ashoka D and Camp, II, David G and Smith, Richard D},
abstractNote = {A method for identifying persons with increased risk of developing type 2 diabetes mellitus utilizing selected biomarkers described hereafter either alone or in combination. The present invention allows for broad based, reliable, screening of large population bases and provides other advantages, including the formulation of effective strategies for characterizing, archiving, and contrasting data from multiple sample types under varying conditions.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2014},
month = {3}
}

Patent:

Save / Share:

Works referenced in this record:

Assay for Diabetes
patent-application, August 2008


Application of Proteomics in the Discovery of Candidate Protein Biomarkers in a Diabetes Autoantibody Standardization Program Sample Subset
journal, February 2008